Influenza in Humans Clinical Trial
Official title:
A Phase-1, Open-label, Four Group, Fixed-Sequence Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir, JNJ-63623872, and Probes for P-glycoprotein, CYP3A and OATP1B1 in Healthy Volunteers
This open-label, four group, fixed-sequence study will evaluate the safety and pharmacokinetic interaction of AL-794 on oseltamivir, JNJ-63623872 (formerly VX-787) and probes for P-glycoprotein, CYP3A and OATP1B1 in healthy volunteers.
This open-label, four group, fixed-sequence study will evaluate the safety and
pharmacokinetic interaction of AL-794 on oseltamivir, JNJ-63623872 (formerly VX-787) and
probes for P-glycoprotein, CYP3A and OATP1B1 in healthy volunteers.
For each group, the study consists of an eligibility screening period, study period, and 1
follow-up visit. Groups may enroll in parallel but subjects enrolled in one group may not
participate in another group.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01014364 -
Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu
|
Phase 3 |